Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Cerilliant
Chubb
Covington
Harvard Business School
Fuji
McKinsey
Cipla
Moodys

Generated: May 21, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,387,089

« Back to Dashboard

Summary for Patent: 4,387,089
Title: 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane
Abstract:The novel 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane is useful as a sunscreen agent. It exhibits outstanding UV-A absorbing qualities in that it brings about a considerable retardation in the ageing of the skin with excellent skin tolerance and stability (light, heat and moisture). 4-(1,1-Dimethylethyl)-4'-methoxydibenzoylmethane furthermore improves the protective action of UV B-filters, i.e. of substances which absorb the erythema-producing UV B-radiation in the range of about 290 to 320 mm.
Inventor(s): De Polo; Karl-Fred (Onex, CH)
Assignee: Givaudan Corporation (Clifton, NJ)
Application Number:06/264,774
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 4,387,089
Patent Claim Types:
see list of patent claims
Compound; Composition; Process; Use; Formulation;

Drugs Protected by US Patent 4,387,089

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,387,089

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland11639/78Nov 13, 1978
Switzerland7686/79Aug 23, 1979

International Family Members for US Patent 4,387,089

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Germany 2945125 ➤ Try a Free Trial
Switzerland 642536 ➤ Try a Free Trial
France 2440933 ➤ Try a Free Trial
United Kingdom 2038807 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Daiichi Sankyo
Citi
Boehringer Ingelheim
Moodys
UBS
Julphar
Deloitte
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.